Department of Angiology, Heart Center Bad Krozingen, Germany.
J Endovasc Ther. 2013 Feb;20(1):64-73. doi: 10.1583/12-4014.1.
To determine the clinical and technical outcomes following endovascular therapy for aortoiliac occlusive disease, including complex reconstruction of the aortic bifurcation.
A retrospective database search identified 1184 consecutive patients (864 men; mean age 64±10 years) who underwent 1712 procedures to treat target lesions in the distal aorta and iliac arteries from September 1996 to December 2006. The intended strategy was to open only one femoral access site primarily, so a second puncture was needed only for the kissing balloon technique at the aortic bifurcation. The primary endpoint was a 1-year duplex-based primary patency; secondary endpoints included acute technical success (residual stenosis <30%), secondary patency, and target lesion revascularization (TLR). Results were stratified by lesion morphology, which was classified according to the TransAtlantic Inter-Society Consensus (TASC II) document.
Most of the interventions were done in the iliac arteries (n=1337); 292 cases involved the aortic bifurcation, and 83 cases were in the distal aorta/aortic bifurcation. The mean follow-up was 3.24 years (range 0-12.7). In the entire study cohort, the 12- and 24-month restenosis, TLR, and primary/secondary patency rates did not differ among TASC II A-D subgroups. The symptom-driven TLR in the entire cohort was 8% and 9% at the 12- and 24-month follow-up, leading to secondary patency rates of 96% and 91% in the entire cohort. Outcomes for complex interventions in the distal aorta or aortic bifurcation did not differ significantly compared to the total cohort. The overall survival without restenosis, amputation, or surgery in TASC II subgroups A+B was higher (69.6%±1.5%) compared to TASC II C+D lesions (62.8%±1.9%, p=0.001).
The indication for percutaneous intervention in aortoiliac occlusive disease can be extended to complex TASC C and D lesions in experienced endovascular centers, even if complex reconstruction of the distal aorta or the aortic bifurcation is indicated.
确定腔内治疗主髂动脉闭塞性疾病的临床和技术结果,包括主动脉分叉处的复杂重建。
回顾性数据库检索确定了 1184 例连续患者(864 例男性;平均年龄 64±10 岁),这些患者于 1996 年 9 月至 2006 年 12 月接受了 1712 次治疗以治疗远端主动脉和髂动脉靶病变的手术。主要策略是仅主要开放一个股动脉入路,因此仅在主动脉分叉处需要第二个穿刺进行吻球技术。主要终点是基于双功超声的 1 年原发性通畅率;次要终点包括急性技术成功率(残余狭窄<30%)、继发性通畅率和靶病变血运重建(TLR)。结果根据病变形态进行分层,根据跨大西洋血管内学会共识(TASC II)文件进行分类。
大多数干预措施都是在髂动脉中进行的(n=1337);292 例涉及主动脉分叉,83 例位于远端主动脉/主动脉分叉处。平均随访时间为 3.24 年(范围 0-12.7)。在整个研究队列中,TASC II A-D 亚组之间 12 个月和 24 个月的再狭窄、TLR 和原发性/继发性通畅率没有差异。整个队列中,症状驱动的 TLR 在 12 个月和 24 个月随访时分别为 8%和 9%,导致整个队列的继发性通畅率分别为 96%和 91%。与总队列相比,远端主动脉或主动脉分叉处的复杂干预的结果没有显著差异。TASC II A+B 亚组中无再狭窄、截肢或手术的总体生存率较高(69.6%±1.5%),而 TASC II C+D 病变(62.8%±1.9%)较高,差异有统计学意义(p=0.001)。
在有经验的血管内治疗中心,经皮介入治疗主髂动脉闭塞性疾病的适应证可以扩展到复杂的 TASC C 和 D 病变,即使需要对远端主动脉或主动脉分叉处进行复杂重建。